Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 1, 2015
Grant Date -
Apr 12, 2012
app pub date -
Apr 5, 2010
filing date -
Apr 6, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to a combination product for treating or ameliorating hepatitis C virus (HCV) infection or disorders or symptoms associated therewith in a subject in need thereof comprising, a HCV inhibitor and one or more therapeutic agents selected from either or both a HCV protease inhibitor and one or more different therapeutic agents administered in combination in an effective amount to the subject.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully